^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Genome Insight

    i
    Other names: Genome Insight
    Related tests:
    Evidence

    News

    3ms
    Genome insight receives College of American Pathologists Accreditation for reliable whole genome sequencing (Businesswire)
    "Genome Insight...announce its accreditation by the College of American Pathologists (CAP) for its whole genome sequencing services. The CAP accreditation, effective January 2024, solidifies Genome Insight's status as a trusted provider of high quality and reliable genomic services."
    Regulatory
    5ms
    Genome Insight to Unveil Hong Kong Real-World Evidence on Target Enhanced Whole Genome Sequencing at 2023 AACR-KCA Joint Conference (Businesswire)
    "Genome Insight...will announce new-real-world evidence from Hong Kong on the application of Target Enhanced Whole Genome Sequencing (TE-WGS) at the 2023 AACR-KCA joint conference on Precision Medicine in Cancer in Seoul, Korea...Genome Insight's presentation will feature the outcomes of a collaborative real-world evidence program on TE-WGS in lung cancers. The program focused on non-small cell lung adenocarcinoma and drew on a TE-WGS pipeline exclusively designed for solid tumors, known as CancerVision...Genome Insight will present the case of a 78-year-old Asian man from Hong Kong with poorly differentiated Non-Small Cell Lung Cancer (NSCLC)....The results indicated that CancerVision was able to detect actionable biomarkers, including MET gene amplification with a Gene Copy Number (GCN) of 8, a high TMB of 14.88 muts/mb, and a tobacco-smoking-induced whole-genome sequencing signature."
    Real-world evidence
    6ms
    Genome Insight secures another $23M in second Series B round (Genomeweb)
    "Precision medicine company Genome Insight announced on Wednesday that it closed a $23 million Series B-2 financing round...The San Diego-based company said in a statement that it plans to use the funds to support its goal of bringing whole-genome-based precision diagnostics into routine clinical care."
    Financing
    12ms
    Genome Insight launches in the U.S. with innovative whole genome sequencing approach that offers unprecedented, actionable insights in cancer care (PRNewswire)
    "Genome Insight...announced today the U.S. launch of CancerVision, their innovative whole genome sequencing (WGS) test designed to provide accurate, timely and medically meaningful insights that collectively guide personalized healthcare decisions."
    Launch US
    |
    CancerVision
    1year
    Genome Insight's innovative whole genome sequencing approach to be showcased at AACR (American Association of Cancer Research) Annual Meeting 2023 (Newswire)
    "Genome Insight...announced that their innovative whole genome sequencing (WGS) approach will be featured in six poster presentations at the American Association of Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL. These posters cover a range of topics, including a study of integrative biomarker analysis of regorafenib plus nivolumab (RegoNivo) in hepatocellular carcinoma (HCC), as well as a comparison between whole-genome sequencing-based and targeted panel sequencing approaches to precision oncology."
    Clinical data
    1year
    Ultima Genomics, Genome Insight partner on low-cost whole-genome sequencing for cancer patients (Genomeweb)
    "Ultima Genomics and Genome Insight said on Monday that they are collaborating to develop affordable whole-genome sequencing testing for cancer patients...As part of the agreement, Genome Insight will join the early-access program for Ultima's high-throughput sequencing platform, the UG 100, and optimize its whole-genome bioinformatics algorithm for cancer analysis using Ultima's sequencing technology."
    Licensing / partnership